# NewLake Capital Partners, Inc.: financial statements, quarterly

NLCP · OTC · CIK 1854964 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nlcp.md) · [Financials](/companies/nlcp/financials.md) · [Filings](/companies/nlcp/filings.md) · [Insiders](/companies/nlcp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nlcp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [11.5](/filings/0001854964-24-000050.md) | [13.0 d](/filings/0001854964-25-000004.md) | [12.6](/filings/0001628280-25-023915.md) | [12.5](/filings/0001854964-25-000009.md) | [12.6](/filings/0001854964-25-000022.md) | [12.5 d](/filings/0001854964-26-000006.md) | [13.2](/filings/0001854964-26-000017.md) | [12.9](/filings/0001854964-26-000028.md) | [12.6](/filings/0001854964-25-000022.md) | [12.3 d](/filings/0001854964-26-000006.md) | [12.3](/filings/0001854964-26-000017.md) | [12.1](/filings/0001854964-26-000028.md) |
| Operating income | $m | [6.0](/filings/0001854964-24-000050.md) | [7.0 d](/filings/0001854964-25-000004.md) | [7.0](/filings/0001628280-25-023915.md) | [7.0](/filings/0001854964-25-000009.md) | [6.6](/filings/0001854964-25-000022.md) | [6.2 d](/filings/0001854964-26-000006.md) | [6.5](/filings/0001854964-26-000017.md) | [7.6](/filings/0001854964-26-000028.md) | [6.9](/filings/0001854964-25-000022.md) | [6.3 d](/filings/0001854964-26-000006.md) | [6.0](/filings/0001854964-26-000017.md) | [6.1](/filings/0001854964-26-000028.md) |
| Interest expense | $m | [0.1](/filings/0001854964-23-000041.md) | [0.1 d](/filings/0001854964-24-000007.md) | [0.1](/filings/0001854964-24-000029.md) | [0.1](/filings/0001854964-25-000009.md) | [0.2](/filings/0001854964-25-000022.md) | [0.2 d](/filings/0001854964-26-000006.md) | [0.2](/filings/0001854964-26-000017.md) | [0.2](/filings/0001854964-26-000028.md) | [0.2](/filings/0001854964-25-000022.md) | [0.2 d](/filings/0001854964-26-000006.md) | [0.2](/filings/0001854964-26-000017.md) | [0.2](/filings/0001854964-26-000028.md) |
| Net income | $m | [6.0](/filings/0001854964-24-000050.md) | [7.0 d](/filings/0001854964-25-000004.md) | [6.9](/filings/0001628280-25-023915.md) | [6.8](/filings/0001854964-25-000009.md) | [6.4](/filings/0001854964-25-000022.md) | [6.0 d](/filings/0001854964-26-000006.md) | [6.3](/filings/0001854964-26-000017.md) | [7.3](/filings/0001854964-26-000028.md) | [6.7](/filings/0001854964-25-000022.md) | [6.0 d](/filings/0001854964-26-000006.md) | [5.8](/filings/0001854964-26-000017.md) | [5.9](/filings/0001854964-26-000028.md) |
| Diluted EPS | $ per share | [0.28](/filings/0001854964-24-000050.md) | not reported | [0.33](/filings/0001628280-25-023915.md) | [0.33](/filings/0001854964-25-000009.md) | [0.31](/filings/0001854964-25-000022.md) | not reported | [0.31](/filings/0001854964-26-000017.md) | [0.35](/filings/0001854964-26-000028.md) | [0.32](/filings/0001854964-25-000022.md) | not reported | [0.28](/filings/0001854964-26-000017.md) | [0.29](/filings/0001854964-26-000028.md) |
| Basic EPS | $ per share | [0.28](/filings/0001854964-24-000050.md) | not reported | [0.33](/filings/0001628280-25-023915.md) | [0.33](/filings/0001854964-25-000009.md) | [0.31](/filings/0001854964-25-000022.md) | not reported | [0.31](/filings/0001854964-26-000017.md) | [0.36](/filings/0001854964-26-000028.md) | [0.32](/filings/0001854964-25-000022.md) | not reported | [0.28](/filings/0001854964-26-000017.md) | [0.29](/filings/0001854964-26-000028.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [31.1](/filings/0001854964-23-000041.md) | [25.8](/filings/0001854964-25-000004.md) | [21.5](/filings/0001854964-24-000029.md) | [20.7](/filings/0001854964-24-000041.md) | [19.8](/filings/0001854964-24-000050.md) | [20.2](/filings/0001854964-26-000006.md) | [19.9](/filings/0001628280-25-023915.md) | [21.9](/filings/0001854964-25-000009.md) | [23.6](/filings/0001854964-25-000022.md) | [23.9](/filings/0001854964-26-000028.md) | [24.8](/filings/0001854964-26-000017.md) | [25.8](/filings/0001854964-26-000028.md) |
| Total assets | $m | [435](/filings/0001854964-23-000041.md) | [433](/filings/0001854964-25-000004.md) | [433](/filings/0001854964-24-000029.md) | [436](/filings/0001854964-24-000041.md) | [435](/filings/0001854964-24-000050.md) | [432](/filings/0001854964-26-000006.md) | [428](/filings/0001628280-25-023915.md) | [426](/filings/0001854964-25-000009.md) | [424](/filings/0001854964-25-000022.md) | [421](/filings/0001854964-26-000028.md) | [418](/filings/0001854964-26-000017.md) | [415](/filings/0001854964-26-000028.md) |
| Total liabilities | $m | [19.7](/filings/0001854964-23-000041.md) | [21.3](/filings/0001854964-25-000004.md) | [22.5](/filings/0001854964-24-000029.md) | [27.3](/filings/0001854964-24-000041.md) | [27.7](/filings/0001854964-24-000050.md) | [27.6](/filings/0001854964-26-000006.md) | [26.4](/filings/0001628280-25-023915.md) | [26.3](/filings/0001854964-25-000009.md) | [26.4](/filings/0001854964-25-000022.md) | [26.1](/filings/0001854964-26-000028.md) | [26.0](/filings/0001854964-26-000017.md) | [26.0](/filings/0001854964-26-000028.md) |
| Shareholders' equity | $m | [408](/filings/0001854964-23-000041.md) | [405](/filings/0001854964-25-000004.md) | [403](/filings/0001854964-24-000029.md) | [402](/filings/0001854964-24-000041.md) | [400](/filings/0001854964-24-000050.md) | [397](/filings/0001854964-26-000006.md) | [394](/filings/0001628280-25-023915.md) | [393](/filings/0001854964-25-000009.md) | [391](/filings/0001854964-25-000022.md) | [388](/filings/0001854964-26-000028.md) | [385](/filings/0001854964-26-000017.md) | [382](/filings/0001854964-26-000028.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [9.4 d](/filings/0001854964-24-000050.md) | [12.5 d](/filings/0001854964-25-000004.md) | [10.0](/filings/0001628280-25-023915.md) | [11.7 d](/filings/0001854964-25-000009.md) | [11.0 d](/filings/0001854964-25-000022.md) | [10.6 d](/filings/0001854964-26-000006.md) | [10.2](/filings/0001854964-26-000017.md) | [11.5 d](/filings/0001854964-26-000028.md) | [10.7 d](/filings/0001854964-25-000022.md) | [10.1 d](/filings/0001854964-26-000006.md) | [10.4](/filings/0001854964-26-000017.md) | [10.5 d](/filings/0001854964-26-000028.md) |
| Dividends paid | $m | [8.3 d](/filings/0001854964-24-000050.md) | [8.1 d](/filings/0001854964-25-000004.md) | [8.2](/filings/0001628280-25-023915.md) | [8.4 d](/filings/0001854964-25-000009.md) | [8.8 d](/filings/0001854964-25-000022.md) | [8.8 d](/filings/0001854964-26-000006.md) | [8.8](/filings/0001854964-26-000017.md) | [8.8 d](/filings/0001854964-26-000028.md) | [8.8 d](/filings/0001854964-25-000022.md) | [8.8 d](/filings/0001854964-26-000006.md) | [8.8](/filings/0001854964-26-000017.md) | [8.8 d](/filings/0001854964-26-000028.md) |
| Share repurchases | $m | [7.9 d](/filings/0001854964-24-000050.md) | [2.6 d](/filings/0001854964-25-000004.md) | [0.0](/filings/0001854964-24-000029.md) | [0.0 d](/filings/0001854964-24-000041.md) | [0.0 d](/filings/0001854964-24-000050.md) | [0.0 d](/filings/0001854964-25-000004.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [21.8](/filings/0001854964-23-000041.md) | [21.8](/filings/0001854964-24-000029.md) | [21.7](/filings/0001854964-24-000041.md) | [21.6](/filings/0001854964-24-000050.md) | [20.9](/filings/0001628280-25-023915.md) | [21.0](/filings/0001854964-25-000009.md) | [21.0](/filings/0001854964-25-000022.md) | [21.0](/filings/0001854964-26-000017.md) | [21.0](/filings/0001854964-26-000028.md) | [21.0](/filings/0001854964-25-000022.md) | [21.0](/filings/0001854964-26-000017.md) | [21.0](/filings/0001854964-26-000028.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 20,580,766 at 2026-08-04, from the cover of the [10-Q filed 2026-08-06](/filings/0001854964-26-000028.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.